Sorafenib, sold under the brand name Nexavar, [3] is a kinase inhibitor drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma), advanced primary liver …

Sorafenib is used to treat late-stage kidney cancer (advanced renal cell carcinoma), liver cancer (hepatocellular carcinoma) that cannot be treated by surgery, and differentiated thyroid cancer …

2024年3月14日 · What is sorafenib? Sorafenib is used in adults to treat liver cancer, thyroid cancer, or kidney cancer. Sorafenib may also be used for purposes not listed in this …

Sorafenib is a medication that stops cancer cells from growing. It treats liver cancer, kidney cancer and thyroid cancer. This medication comes as a tablet that you can take by mouth with …

Sorafenib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps stop the spread of cancer cells.

Sorafenib is a prescription medicine used in the treatment of hepatocellular carcinoma (a type of liver cancer), renal cell carcinoma (a type of kidney cancer), and differentiated thyroid …

2024年12月10日 · Sorafenib is a kinase inhibitor that decreases tumor cell proliferation in vitro. Sorafenib was shown to inhibit multiple intracellular (c-CRAF, BRAF and mutant BRAF) and …

2018年6月22日 · Sorafenib is an oral multi-kinase inhibitor that is used in the therapy of advanced renal cell, liver and thyroid cancer. Sorafenib has been associated with a low rate of transient …

Sorafenib (Nexavar®) is a targeted therapy drug. It is used to treat some types of kidney, liver and thyroid cancers. Learn more about it.

Medscape - Indication-specific dosing for Nexavar (sorafenib), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost...